Why Summits

World Drug Safety Summit

5–6 Jun 2025 | Basel, Switzerland

Novartis

Manufacturer

Basel, Switzerland
2 profile visits

About

At Novartis, we are dedicated to reimagining medicine to improve and extend people's lives. As a global healthcare company, we focus on innovative pharmaceuticals and groundbreaking therapies that address significant health challenges. Our commitment to research and development drives us to collaborate with healthcare professionals, scientists, and patients to create solutions that make a meaningful impact. Together, we strive to build a healthier future for communities around the world.

Risk Management & Strategy

Global pharmacovigilance strategy

Data Science, RWE, and Analytics

Use of Real-World Data (RWD) and Real-World Evidence (RWE)

Pharmacovigilance Operations

Signal detection and evaluationRisk Management Plan (RMP) developmentBenefit-Risk assessment

Digital Innovation & AI in PV

AI in signal management and safety decision-makingAutomation of safety reporting and workflows

Regulatory Affairs & Compliance

GVP inspection preparedness and survival strategies

Representatives

Luvanka Hanxhari

Senior Manager Aggregate Reports & Risk Management – RMP

Novartis

Petros Mavrogenis

Global Head of Vigilance Process Excellence

Novartis

Marketplace (1)

  • Expertise

    Vision and expertise sharing

    Happy to exchange visions on a path for AI enhanced PV

    • Digital Solutions & AI
    • Pharmacovigilance & Drug Safety
    • Cross-Functional Safety Strategy
    Author

    Fiorenza Gaudenzi

    Senior Global Program Safety Team Lead at Novartis

    Basel, Switzerland